Baird Downgrades Asana to Neutral, Lowers Price Target to $15

Baird analyst Rob Oliver downgrades Asana (NYSE:ASAN) from Outperform to Neutral and lowers the price target from $32 to $15.

Baird analyst Rob Oliver downgrades Asana (NYSE:ASAN) from Outperform to Neutral and lowers the price target from $32 to $15.

Total
0
Shares
Related Posts
Read More

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: “Devastating Risks” Ahead

In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating risks to millions of people," including those in states where abortion remains legal.

BBH